On May 16, the next day after the Belt and Road Forum for International Cooperation closed, one of the participants, Zeman, President of the Czech Republic paid a visit to Nanjing and Li Qiang, Secretary of Jiangsu Provincial Party Committee and Chairman of the Standing Committee of Jiangsu Provincial People's Congress met with him in Nanjing. Yuan Yafei, Chairman of the Board in Sanpower Group attended this meeting.

Li Qiang, Secretary of Jiangsu Provincial Party Committee and Chairman of the Standing Committee of Jiangsu Provincial People's Congress met with Zeman, President of the Czech Republic, in Nanjing.

Yuan Yafei, Chairman of the Board in Sanpower Group attended this meeting.

Li Qiang remarked that under the framework of "the Belt and Road" Initiative, he is willing to promote the friendly cooperation between Jiangsu and Czech, further promote the economic trade cooperation, promote the industrial investment cooperation, increase people-to-people exchanges, enhance pragmatic cooperation in fields such as education, culture, tourism, sports and health and thus promote the continuous development of the friendly relationship between China and the Czech Republic. After the meeting, witnessed by Li Qiang and Zeman, Sanpower Group signed a memorandum of cooperation with Sotio, a famous biomedicine enterprise in the Czech Republic and both sides will conduct cooperation and communication in the field of cell therapy. Yue Lei, senior vice president of Sanpower Group, and VladimírHrusa, general manager of Sotio in China district, have signed the agreement on behalf of both sides. Meanwhile, Jiangsu Provincial Commission of Health and Family Planning and Jiangsu Provincial Education Department have signed cooperation documents with Czech in the fields such as health and education.

As a local enterprise in Jiangsu, Sanpower Group takes an active part in the construction of "the Belt and Road" and has made great achievements. This time, by seizing the opportunity of Belt and Road Forum for International Cooperation, it has signed the cooperative agreement with Czech pharmaceutical enterprise to deepen and consolidate the economic trade achievement of "the Belt and Road".

Affiliated to PPF Group, the largest investment group in Central and Eastern Europe ,Sotio is an international company specializing in research, development and application of cell therapy with a strong international R&D team. With a business network in Europe, America, Russia and China, it established the cell therapy production lab in China conforming to the GMP standard in 2014. By contrast, this January, Sanpower Group signed to acquire Provenge, the only drug of treating prostate cancer approved by FDA in America and both sides share the solid foundation and promising future for cooperation.

Before the formal signing of cooperative agreement, both sides have reached the consensus through many rounds of consultation. On February 15, 2017, the top management team of Sotio paid a visit to Sanpower Group for the first time and both sides have discussed cooperation in tumor immunotherapy, biological medical science research and hospital construction and management. After that, the top management team of Sanpower Group went to Prague in Czech to pay a return visit to Sotio and investigate its medical and research facilities. Meanwhile, they had an in-depth discussion of future cooperation. After three months of close negotiation, cooperation agreement has been finalized.

According to the agreement, by relying on their own advantages and resources, both sides will carry out cooperation and communication in science research in cell therapy and regularly carry out training in cell therapy; meanwhile, they will carry out research and cooperation in terms of cell product manufacturing standards, preparation technology, flow and quality control and cell therapy production lab use and operation. Furthermore, both sides will facilitate the investment cooperation and communication between Sanpower Group and PPF Group in different fields in China, Europe and America.

Yuan Yafei, Chairman of Sanpower Group remarked that through this cooperation, he hopes to help Chinese patients to use world's leading cellular immunotherapy as soon as possible and make contribution to the development of "Healthy Jiangsu" and "Healthy China".

Li Qiang and Zeman jointly witnessed the signing of cooperation documents between Jiangsu Provincial Commission of Health and Family Planning, Jiangsu Provincial Education Department, Sanpower Group and Czech in health, education and industry.